Cargando…
异基因造血干细胞移植治疗T淋巴母细胞白血病/淋巴瘤的疗效及预后因素
OBJECTIVE: To analyze the efficacy and prognostic factors of allogeneic hematopoietic stem cell transplantation(allo-HSCT)for treating T lymphoblastic leukemia/lymphoma(T-ALL/LBL). METHODS: This study retrospectively evaluated 119 adolescent and adult patients with T-ALL/LBL from January 2006 to Jan...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10440623/ https://www.ncbi.nlm.nih.gov/pubmed/37550188 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2023.05.006 |
Ejemplares similares
-
ALL儿童方案序贯造血干细胞移植治疗T淋巴母细胞淋巴瘤疗效及预后因素分析
Publicado: (2020) -
异基因造血干细胞移植治疗外周T细胞淋巴瘤研究进展
Publicado: (2016) -
自体造血干细胞移植治疗T淋巴母细胞淋巴瘤41例临床研究
Publicado: (2020) -
成人急性淋巴细胞白血病自体和异基因造血干细胞移植疗效对比分析
Publicado: (2015) -
造血干细胞移植治疗血管免疫母细胞性T细胞淋巴瘤临床分析
Publicado: (2019)